Bharat Biotech and GSK announce price reduction for the world's first malaria vaccine to under $5. This move aims to improve access and save thousands of children in malaria-endemic countries.

HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s first malaria vaccine – RTS,S or Mosquirix – by over half to ...

Bharat Biotech, an established supplier to global vaccine alliance Gavi, quickly signed on to help with antigen manufacturing in a product transfer agreement meant to boost the long-term supply of ...

Candidate: COVAXIN™ Category: VAX Type: Whole-virion, inactivated SARS-CoV-2 vaccine manufactured using a Vero Cell manufacturing platform and inactivated with alum as adjuvant 2021 Status: EUA ...

Item 1 of 2 Rupali Deshraj Nirmal, 16, reacts as she receives a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination drive for children aged 15-18 in Mumbai, India, January 3 ...

Emails between Bharat Biotech and the ministry submitted to CPI showed an initial quoted price of $1.34 per dose, which later rose to $15 per dose in the negotiated contract, according to a CPI ...

Bharat Biotech’s Mohan, however, maintained that the company felt confident proceeding to Phase 3 as it did, given results in animal testing, and that the decision to settle on dosing was ...

Indian vaccine maker Bharat Biotech is seeking international manufacturing partners as it targets a billion doses of its COVID-19 vaccine each year, the company said on Sunday.

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save thousands of children who suffer from malaria.